1
|
Kanagasabai U, Valleau C, Cain M, Chevalier MS, Hegle J, Patel P, Benevides R, Trika JB, Angumua C, Mpingulu M, Ferdinand K, Sida F, Galloway K, Kambona C, Oluoch P, Msungama W, Katengeza H, Correia D, Duffy M, Cossa RMV, Coomer R, Ayo A, Ukanwa C, Tuyishime E, Dladla S, Drummond J, Magesa D, Kitalile J, Apondi R, Okuku J, Chisenga T, Cham HJ. Understanding Gender-Based Violence Service Delivery in CDC-Supported Health Facilities: 15 Sub-Saharan African Countries, 2017-2021. AIDS Educ Prev 2023; 35:39-51. [PMID: 37406144 DOI: 10.1521/aeap.2023.35.suppa.39] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/07/2023]
Abstract
Gender-based violence (GBV) is a complex issue deeply rooted in social structures, making its eradication challenging. GBV increases the risk of HIV transmission and is a barrier to HIV testing, care, and treatment. Quality clinical services for GBV, which includes the provision of HIV postexposure prophylaxis (PEP), vary, and service delivery data are lacking. We describe GBV clinical service delivery in 15 countries supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention. Through a descriptive statistical analysis of PEPFAR Monitoring, Evaluation, and Reporting (MER) data, we found a 252% increase in individuals receiving GBV clinical services, from 158,691 in 2017 to 558,251 in 2021. PEP completion was lowest (15%) among 15-19-year-olds. Understanding GBV service delivery is important for policy makers, program managers, and providers to guide interventions to improve the quality of service delivery and contribute to HIV epidemic control.
Collapse
Affiliation(s)
- Udhayashankar Kanagasabai
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | | | - Meagan Cain
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | - Michelle S Chevalier
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | - Jennifer Hegle
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | - Pragna Patel
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | - Regina Benevides
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| | - Joseph B Trika
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Carrine Angumua
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Minlangu Mpingulu
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Kamanga Ferdinand
- The following authors are affiliated with their respective country's Ministry of Health: Kamanga Ferdinand (Democratic Republic of Congo), Hans Katengeza (Malawi), Raquel Maria Violeta Cossa (Mozambique), Chioma Ukanwa (Nigeria), and Tina Chisenga (Zambia)
| | - Fikirte Sida
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Katelyn Galloway
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Caroline Kambona
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Patricia Oluoch
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Wezi Msungama
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Hans Katengeza
- The following authors are affiliated with their respective country's Ministry of Health: Kamanga Ferdinand (Democratic Republic of Congo), Hans Katengeza (Malawi), Raquel Maria Violeta Cossa (Mozambique), Chioma Ukanwa (Nigeria), and Tina Chisenga (Zambia)
| | - Della Correia
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Meghan Duffy
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Raquel Maria Violeta Cossa
- The following authors are affiliated with their respective country's Ministry of Health: Kamanga Ferdinand (Democratic Republic of Congo), Hans Katengeza (Malawi), Raquel Maria Violeta Cossa (Mozambique), Chioma Ukanwa (Nigeria), and Tina Chisenga (Zambia)
| | - Rachel Coomer
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Adeola Ayo
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Chioma Ukanwa
- The following authors are affiliated with their respective country's Ministry of Health: Kamanga Ferdinand (Democratic Republic of Congo), Hans Katengeza (Malawi), Raquel Maria Violeta Cossa (Mozambique), Chioma Ukanwa (Nigeria), and Tina Chisenga (Zambia)
| | - Elysee Tuyishime
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Sibongile Dladla
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Jennifer Drummond
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Daniel Magesa
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Jane Kitalile
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Rose Apondi
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Jackson Okuku
- The following authors are affiliated with the respective country offices of the Division of Global HIV and TB, CGH, CDC: Joseph B. Trika (Cote d'Ivoire), Carrine Angumua (Cameroon), Minlangu Mpingulu (Democratic Republic of Congo), Fikirte Sida (Ethiopia), Katelyn Galloway (Eswatini), Caroline Kambona and Patricia Oluoch (Kenya), Wezi Msungama (Malawi), Della Correia, and Meghan Duffy (Mozambique), Rachel Coomer (Namibia), Adeola Ayo (Nigeria), Elysee Tuyishime (Rwanda), Sibongile Dladla, and Jennifer Drummond (South Africa), Daniel Magesa, and Jane Kitalile (Tanzania), Rose Apondi (Uganda), and Jackson Okuku (Zambia)
| | - Tina Chisenga
- The following authors are affiliated with their respective country's Ministry of Health: Kamanga Ferdinand (Democratic Republic of Congo), Hans Katengeza (Malawi), Raquel Maria Violeta Cossa (Mozambique), Chioma Ukanwa (Nigeria), and Tina Chisenga (Zambia)
| | - Haddi J Cham
- Division of Global HIV and TB, Center for Global Health (CGH), U.S. Centers for Disease Control and Prevention (CDC), Atlanta Georgia
| |
Collapse
|
3
|
Koros DK, Ondondo RO, Junghae M, Oluoch P, Chesang K. NATIONAL HIV TESTING CAMPAIGNS TO SUPPORT UNAIDS 90-90-90 AGENDA: A LESSON FROM KENYA. East Afr Med J 2021; 97:3295-3302. [PMID: 37204967 PMCID: PMC10191107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Background HIV diagnosis is the gateway to antiretroviral therapy. However, 20-50% of HIV-infected individuals are unaware of their HIV status, derailing epidemic control. Objective To increase awareness of HIV status and enrollment into HIV care & treatment (C&T) services through a national HIV testing services (HTS) rapid results initiative (RRI) campaign in Kenya. Design This cross-sectional analysis presents yield of undiagnosed people living with HIV (PLHIV) and their enrollment into HIV C&T resulting from HTS RRI implemented in July-August 2013 as an example of utilizing RRIs to catalyze achievement of UNAIDS targets. Results During the campaign 1,462,378 persons received HTS, of whom 220,902 (15%) were children (aged <15 years), 55,088 (7%) couples and 116,126 (8%) key populations. A total of 37,630 (2.6%) HIV+ individuals were identified. Among children who received HTS, 3,244 (1.5%) tested HIV positive, compared to 34,386 (2.8%) among adults. Of the eight regions in Kenya: Nyanza, Rift-valley and Nairobi contributed 73.3% of all HIV+ individuals identified. HTS at health facility settings yielded the highest proportion (69%) of HIV+ and key populations had the highest prevalence (4.8%). Of those infected, 29,851 (79.3%) were enrolled into HIV C&T. Sex, age and setting of HTS were significantly associated with enrollment into HIV C&T (p<0.0001). Conclusion National HTS campaigns have the potential of increasing knowledge of HIV status. Targeted provision of HTS at health facility settings, to key populations and high burden geographical regions would narrow the gap of undiagnosed PLHIV towards achieving UNIADS 90-90-90 targets for HIV epidemic control.
Collapse
Affiliation(s)
- D K Koros
- Dan Kipkorir Koros, The President's Emergency Plan For AIDS Relief (PEPFAR), Nairobi, Kenya, P.O. Box 606, Village Market 00621, Nairobi, Kenya,Raphael Omusebe Ondondo, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Muthoni Junghae, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Patricia Oluoch, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Kipruto Chesang, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621,Nairobi, Kenya
| | - R O Ondondo
- Dan Kipkorir Koros, The President's Emergency Plan For AIDS Relief (PEPFAR), Nairobi, Kenya, P.O. Box 606, Village Market 00621, Nairobi, Kenya,Raphael Omusebe Ondondo, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Muthoni Junghae, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Patricia Oluoch, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Kipruto Chesang, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621,Nairobi, Kenya
| | - M Junghae
- Dan Kipkorir Koros, The President's Emergency Plan For AIDS Relief (PEPFAR), Nairobi, Kenya, P.O. Box 606, Village Market 00621, Nairobi, Kenya,Raphael Omusebe Ondondo, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Muthoni Junghae, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Patricia Oluoch, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Kipruto Chesang, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621,Nairobi, Kenya
| | - P Oluoch
- Dan Kipkorir Koros, The President's Emergency Plan For AIDS Relief (PEPFAR), Nairobi, Kenya, P.O. Box 606, Village Market 00621, Nairobi, Kenya,Raphael Omusebe Ondondo, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Muthoni Junghae, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Patricia Oluoch, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Kipruto Chesang, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621,Nairobi, Kenya
| | - K Chesang
- Dan Kipkorir Koros, The President's Emergency Plan For AIDS Relief (PEPFAR), Nairobi, Kenya, P.O. Box 606, Village Market 00621, Nairobi, Kenya,Raphael Omusebe Ondondo, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Muthoni Junghae, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Patricia Oluoch, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621, Nairobi, Kenya, Kipruto Chesang, Division Of Global HIV&TB, U.S. Centers For Disease Control and Prevention (CDC), P.O. Box 606, Village Market 00621,Nairobi, Kenya
| |
Collapse
|
4
|
Masyuko S, Mukui I, Njathi O, Kimani M, Oluoch P, Wamicwe J, Mutegi J, Njogo S, Anyona M, Muchiri P, Maikweki L, Musyoki H, Bahati P, Kyongo J, Marwa T, Irungu E, Kiragu M, Kioko U, Ogando J, Were D, Bartilol K, Sirengo M, Mugo N, Baeten JM, Cherutich P, PrEP Technical Working Group OBOT. Pre-exposure prophylaxis rollout in a national public sector program: the Kenyan case study. Sex Health 2019; 15:578-586. [PMID: 30408432 DOI: 10.1071/sh18090] [Citation(s) in RCA: 54] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Accepted: 09/29/2018] [Indexed: 12/20/2022]
Abstract
Background While advances have been made in HIV prevention and treatment, new HIV infections continue to occur. The introduction of pre-exposure prophylaxis (PrEP) as an additional HIV prevention option for those at high risk of HIV may change the landscape of the HIV epidemic, especially in sub-Saharan Africa, which bears the greatest HIV burden. METHODS This paper details Kenya's experience of PrEP rollout as a national public sector program. The process of a national rollout of PrEP guidance, partnerships, challenges, lessons learnt and progress related to national scale up of PrEP in Kenya, as of 2018, is described. National rollout of PrEP was strongly lead by the government, and work was executed through a multidisciplinary, multi-organisation dedicated team. This required reviewing available evidence, providing guidance to health providers, integration into existing logistic and health information systems, robust communication and community engagement. Mapping of the response showed that subnational levels had existing infrastructure but required targeted resources to catalyse PrEP provision. Rollout scenarios were developed and adopted, with prioritisation of 19 counties focusing on high incidence area and high potential PrEP users to maximise impact and minimise costs. RESULTS PrEP is now offered in over 900 facilities countrywide. There are currently over 14000 PrEP users 1 year after launching PrEP. CONCLUSIONS Kenya becomes the first African country to rollout PrEP as a national program, in the public sector. This case study will provide guidance for low- and middle-income countries planning the rollout of PrEP in response to both generalised and concentrated epidemics.
Collapse
Affiliation(s)
- Sarah Masyuko
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Irene Mukui
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Olivia Njathi
- Clinton Health Access Initiative, Timau Plaza, 3rd Floor, Argwings Kodhek Road, Nairobi, Kenya
| | - Maureen Kimani
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Patricia Oluoch
- Centers for Disease Control, KEMRI Complex, Mbagathi Road off Mbagathi Way, Nairobi, Kenya
| | - Joyce Wamicwe
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Jane Mutegi
- Jhpiego, Ring Road, 14 Riverside, Nairobi, Kenya
| | - Susan Njogo
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Micah Anyona
- Jhpiego, Ring Road, 14 Riverside, Nairobi, Kenya
| | - Phillip Muchiri
- Clinton Health Access Initiative, Timau Plaza, 3rd Floor, Argwings Kodhek Road, Nairobi, Kenya
| | - Lucy Maikweki
- Population Services International, Lenana Road, Jumuia Place, Wing B, 2nd Floor, Nairobi, Kenya
| | - Helgar Musyoki
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Prince Bahati
- International AIDS Vaccine Initiative, ABC Place, Building 2, 3rd Floor, Waiyaki Way, Nairobi, Kenya
| | | | - Tom Marwa
- Jhpiego, Ring Road, 14 Riverside, Nairobi, Kenya
| | - Elizabeth Irungu
- Kenya Medical Research Institute, Centre for Clinical Research Laboratories, Nairobi, Kenya
| | | | - Urbanus Kioko
- University of Nairobi, School of Economics, Nairobi, Kenya
| | - Justus Ogando
- Clinton Health Access Initiative, Timau Plaza, 3rd Floor, Argwings Kodhek Road, Nairobi, Kenya
| | - Dan Were
- Jhpiego, Ring Road, 14 Riverside, Nairobi, Kenya
| | - Kigen Bartilol
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Martin Sirengo
- The National AIDS and STI Control Program, Ministry of Health, Afya Annex, Kenyatta National Hospital Grounds, Nairobi, Kenya
| | - Nelly Mugo
- Kenya Medical Research Institute, Centre for Clinical Research Laboratories, Nairobi, Kenya
| | - Jared M Baeten
- University of Washington, 510 San Juan Road, Seattle, WA 98195, USA
| | - Peter Cherutich
- Ministry of Health - Department of Preventive and Promotive Services, Cathedral Road, Nairobi, Kenya
| | | |
Collapse
|